An herbal drug, developed jointly by the National Botanical Research Institute (NBRI) and the Central Institute of Medicinal and Aromatic Plants (CIMAP), branded as BGR-34, has been commercialized by Delhi-based Aimil Pharmaceuticals and marketed as a potentially side-effect free treatment for diabetes. However, a search for publications outlining trials conducted to support the claimed "67% … Continue reading BGR-34 for Diabetes: Where is the evidence?
Anti-Bloomberg Bill in the Soda Wars: Two Wrongs do not Make a Right!
Since posting my rant on the now age old debate about paternalism (or as the people over in USA are calling it: Nanny State) versus public health, I have been reading a lot more about the Soda wars and it emerges that now it is way more hotly debated than ever before. Following in the … Continue reading Anti-Bloomberg Bill in the Soda Wars: Two Wrongs do not Make a Right!